SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-22-000056
Filing Date
2022-11-08
Accepted
2022-11-07 19:44:20
Documents
96
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20220930x10q.htm   iXBRL 10-Q 3023435
2 EX-10.1 amph-20220930xex10d1.htm EX-10.1 507025
3 EX-31.1 amph-20220930xex31d1.htm EX-31.1 19168
4 EX-31.2 amph-20220930xex31d2.htm EX-31.2 18823
5 EX-32.1 amph-20220930xex32d1.htm EX-32.1 9841
6 EX-32.2 amph-20220930xex32d2.htm EX-32.2 9842
  Complete submission text file 0001297184-22-000056.txt   12159124

Data Files

Seq Description Document Type Size
7 EX-101.SCH amph-20220930.xsd EX-101.SCH 61661
8 EX-101.CAL amph-20220930_cal.xml EX-101.CAL 67641
9 EX-101.DEF amph-20220930_def.xml EX-101.DEF 286119
10 EX-101.LAB amph-20220930_lab.xml EX-101.LAB 484670
11 EX-101.PRE amph-20220930_pre.xml EX-101.PRE 456401
90 EXTRACTED XBRL INSTANCE DOCUMENT amph-20220930x10q_htm.xml XML 2464934
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 221366888
SIC: 2834 Pharmaceutical Preparations